What Is The Future Of Using Outcomes-Based Contracts Between Payers And Pharmaceutical Manufacturers To Gain Market Access For Advanced Oncologic And Biologic Agents?
May 1, 2018, 00:00
10.1016/j.jval.2018.04.251
https://www.valueinhealthjournal.com/article/S1098-3015(18)30551-5/fulltext
Title :
What Is The Future Of Using Outcomes-Based Contracts Between Payers And Pharmaceutical Manufacturers To Gain Market Access For Advanced Oncologic And Biologic Agents?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30551-5&doi=10.1016/j.jval.2018.04.251
First page :
Section Title :
Open access? :
No
Section Order :
1127